Published online Oct 15, 2014. doi: 10.4251/wjgo.v6.i10.413
Revised: August 20, 2014
Accepted: September 16, 2014
Published online: October 15, 2014
Processing time: 173 Days and 2 Hours
AIM: To investigate plasma Monocyte Chemotactic Protein-1 levels preoperatively in colorectal cancer (CRC) and benign patients and postoperatively after CRC resection.
METHODS: A plasma bank was screened for minimally invasive colorectal cancer resection (MICR) for CRC and benign disease (BEN) patients for whom preoperative, early postoperative, and 1 or more late postoperative samples (postoperative day 7-27) were available. Monocyte chemotactic protein-1 (MCP-1) levels (pg/mL) were determined via enzyme linked immuno-absorbent assay.
RESULTS: One hundred and two CRC and 86 BEN patients were studied. The CRC patient’s median preoperative MCP-1 level (283.1, CI: 256.0, 294.3) was higher than the BEN group level (227.5, CI: 200.2, 245.2; P = 0.0004). Vs CRC preoperative levels, elevated MCP-1 plasma levels were found on postoperative day 1 (446.3, CI: 418.0, 520.1), postoperative day 3 (342.7, CI: 320.4, 377.4), postoperative day 7-13 (326.5, CI: 299.4, 354.1), postoperative day 14-20 (361.6, CI: 287.8, 407.9), and postoperative day 21-27 (318.1, CI: 287.2, 371.6; P < 0.001 for all).
CONCLUSION: Preoperative MCP-1 levels were higher in CRC patients (vs BEN). After MICR for CRC, MCP-1 levels were elevated for 1 mo and may promote angiogenesis, cancer recurrence and metastasis.
Core tip: In our past published studied we have shown that plasma levels of the pro-angiogenic proteins, vascular endothelial growth factor, angiopoietin-2, placental growth factor, and soluble vascular adhesion molecule-1, are significantly elevated for 2-4 wk following minimally invasive colorectal resection for colorectal cancer (CRC). Additionally, we also showed that postoperative plasma from cancer patients stimulates in vitro endothelial cell proliferation, migration, and invasion, all of which are critical steps in angiogenesis. In this manuscript we are presenting data to show that plasma Monocyte chemotactic protein-1 (MCP-1), a pro-angiogenic protein, in CRC patients remain elevated for month after MICR. Furthermore, we are also showing that the median preoperative plasma level of MCP-1 is significantly higher in the CRC patients than in the BEN group.